Ultra‐Deep Pyrosequencing of Hepatitis B Virus Quasispecies from Nucleoside and Nucleotide Reverse‐Transcriptase Inhibitor (NRTI)–Treated Patients and NRTI‐Naive Patients
Open Access
- 1 May 2009
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 199 (9), 1275-1285
- https://doi.org/10.1086/597808
Abstract
The dynamics of emerging nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI) resistance in hepatitis B virus (HBV) are not well understood because standard dideoxynucleotide direct polymerase chain reaction (PCR) sequencing assays detect drug-resistance mutations only after they have become dominant. To obtain insight into NRTI resistance, we used a new sequencing technology to characterize the spectrum of low-prevalence NRTI-resistance mutations in HBV obtained from 20 plasma samples from 11 NRTI-treated patients and 17 plasma samples from 17 NRTI-naive patients, by using standard direct PCR sequencing and ultra-deep pyrosequencing (UDPS). UDPS detected drug-resistance mutations that were not detected by PCR in 10 samples from 5 NRTI-treated patients, including the lamivudine-resistance mutation V173L (in 5 samples), the entecavir-resistance mutations T184S (in 2 samples) and S202G (in 1 sample), the adefovir-resistance mutation N236T (in 1 sample), and the lamivudine and adefovir–resistance mutations V173L, L180M, A181T, and M204V (in 1 sample). G-to-A hypermutation mediated by the apolipoprotein B mRNA editing enzyme, catalytic polypeptide–like family of cytidine deaminases was estimated to be present in 0.6% of reverse-transcriptase genes. Genotype A coinfection was detected by UDPS in each of 3 patients in whom genotype G virus was detected by direct PCR sequencing. UDPS detected low-prevalence HBV variants with NRTI-resistance mutations, G-to-A hypermutation, and low-level dual genotype infection with a sensitivity not previously possibleKeywords
This publication has 39 references indexed in Scilit:
- Antiviral Resistance Mutations Potentiate hepatitis B virus Immune Evasion through Disruption of its Surface Antigen a DeterminantAntiviral Therapy, 2008
- Antiviral drug-resistant HBV: Standardization of nomenclature and assays and recommendations for managementHepatology, 2007
- Dual effect of APOBEC3G on Hepatitis B virusJournal of General Virology, 2007
- HBV drug resistance: Mechanisms, detection and interpretationJournal of Hepatology, 2006
- Sensitive Line Probe Assay That Simultaneously Detects Mutations Conveying Resistance to Lamivudine and AdefovirJournal of Clinical Microbiology, 2006
- Role and Mechanism of Action of the APOBEC3 Family of Antiretroviral Resistance FactorsJournal of Virology, 2006
- Characteristics of Hepatitis B Virus Isolates of Genotype G and Their Phylogenetic Differences from the Other Six Genotypes (A through F)Journal of Virology, 2002
- A new genotype of hepatitis B virus: complete genome and phylogenetic relatednessMicrobiology, 2000
- Naturally Occurring Variants of Hepatitis B VirusAdvances in virus research, 1999
- Amplimers with 3'-terminal phosphorothioate linkages resist degradation by vent polymerase and reduce Taq polymerase mispriming.Genome Research, 1992